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Complete heart block is the most common electrocardiogram
(ECG) ﬁnding in patients with cardiac sarcoidosis because of
the predilection of granulomatous inﬁltration of the basal
septum or involvement of the atrioventricular nodal artery.1–5
We report a cardiac sarcoid case presenting with sinus
node dysfunction and describe the utility of ﬂuorine-18-
ﬂuorodeoxyglucose positron emission tomography/computed
tomography (18F-FDG PET-CT) scans in making the initial
diagnosis.
Case report
A 44-year-old male endurance athlete with no signiﬁcant
medical history was referred by his primary physician for
cardiac electrophysiological evaluation because of asympto-
matic resting bradycardia (Figure 1A). Right bundle branch
block was present with QRS duration 130 milliseconds and
conducted PR interval of 200 milliseconds. The patient
denied any symptoms such as dizziness, lightheadedness,
presyncope, syncope, or exercise intolerance. He was an avid
athlete and had recently been distance running and cycling
without limitation.
Results of an initial medical evaluation, including thyroid
stimulating hormone, erythrocyte sedimentation rate, and
Lyme titers, were normal. Exercise stress testing revealed
excellent functional capacity (16 metabolic equivalents) and
baseline bradycardia with maximal sinus rate of 130 beatsKEYWORDS Cardiac sarcoidosis; Computed tomography (CT); Fluorine-18-
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arrhythmias were noted during exercise. A transthoracic
echocardiogram showed a left ventricular (LV) ejection
fraction of 55% and normal LV systolic function. Because
of concern for inﬁltrative disease, cardiovascular magnetic
resonance imaging (CMR) was performed; the results
revealed normal biventricular systolic function without
evidence of late gadolinium enhancement. The patient was
scheduled for outpatient follow-up.
Two months after his initial evaluation, the patient
presented with progressive fatigue and exercise intolerance.
An ECG revealed sinus bradycardia at 34 beats per minute, a
conducted PR interval of 422 milliseconds, and a new left
anterior hemiblock in addition to his right bundle branch
block (Figure 1B). Repeat CMR results showed a new
LV basal anteroseptal and mid-posterolateral late gadol-
inium enhancement (Figure 2). A high-resolution chest
computed tomography scan showed no enlarged mediastinal
lymphadenopathy.
Because of high clinical suspicion of cardiac sarcoidosis,
an 18F-FDG PET-CT scan was then performed following
greater than 18 hours of a high-fat, high-protein, low-
carbohydrate diet and injection of intravenous unfractionated
heparin to suppress myocardial 18F-FDG uptake. Results of
myocardial perfusion imaging with intravenous technetium-
99m sestamibi were normal (Figure 3A); however, focal
uptake of 18F-FDG was noted in the right atrium, basal LV
anteroseptum, and basal LV posterolateral wall (Figure 3B).
Focal 18F-FDG uptake in the setting of normal perfusion
imaging is consistent in this case with early disease.6
Multiple foci of 18F-FDG uptake were also noted in the
hilar and paratracheal lymph nodes. Mediastinoscopy was
performed, and results of a lymph node biopsy conﬁrmed
noncaseating granulomatous disease, establishing the diag-
nosis of cardiac sarcoidosis. The patient was initiated on
high-dose steroids and underwent implantation of a dual-
chamber, single-coil primary prevention deﬁbrillator.
A repeat 18F-FDG PET-CT scan was performed 3
months following the initiation of steroid therapy, and thepen access article under the CC BY-NC-ND license
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Figure 2 A repeat cardiac magnetic resonance image, which was taken 2
months after cardiac magnetic resonance imaging with normal results, shows
a small inferior delayed hyperenhancement.
KEY TEACHING POINTS
 Sinus node dysfunction is an uncommon
presentation for cardiac sarcoidosis.
 Cardiac magnetic resonance imaging, despite
proven utility in evaluation for cardiac sarcoidosis,
may not be sufﬁciently sensitive to detect the early
stages of the disease.
 Results of a ﬂuorine-18-ﬂuorodeoxyglucose
positron emission tomography/computed
tomography scan may highlight areas of cardiac
inﬂammation that correlate with clinical disease
activity, identify nonenlarged mediastinal lymph
nodes suitable for biopsy, and help determine
response to steroid therapy.
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Figure 1 A: An electrocardiogram recorded at presentation. B: An electroca
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Figure 3 A: Normal technetium-99m sestamibi rest-and-stress perfusion image. B: Result of a cardiac ﬂuorine-18-ﬂuorodeoxyglucose positron emission
tomography/computed tomography scan. Fluorine-18-ﬂuorodeoxyglucose uptake is present in the right atrium, septum, and lateral left ventricle. C: Repeat
image that was taken after 3 months of steroid therapy. VLA = vertical long axis; HLA = horizontal long axis; APX: = apex; INF = inferior; LAT = lateral;
BAS = basal; SEP = septal.
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Despite a predilection for granulomatous involvement of the
cardiac conduction system, marked sinus nodal inﬂammation
and dysfunction is an uncommon initial presentation for
cardiac sarcoidosis. There are limited case reports of
extensive granulomatous lesions of the sinus node found
during autopsies of cardiac sarcoid patients who experienced
sudden death, and even one case of an obstructive gran-
ulomatous angiitis of the sinus node artery.7,8
The potentially wide clinical expression of cardiac
sarcoidosis, including asymptomatic ECG abnormalities as
in this case, makes initial clinical suspicion and use of
advanced imaging important for early diagnosis. CMR,
despite proven utility in evaluation for cardiac sarcoidosis,
may sometimes not be sufﬁciently sensitive in the early
stages of disease. In our patient, 18F-FDG PET-CT images
revealed extensive right atrial inﬂammation as well as
extensive ventricular inﬂammation. In addition to identifying
areas of cardiac inﬂammation that correlate with clinical
disease activity, 18F-FDG PET-CT images may alsohighlight nonenlarged mediastinal lymph nodes suitable for
biopsy and help determine response to medical therapy.References
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